Corbus Pharmaceuticals Holdings (CRBP) Total Debt Growth (5y) (2018 - 2024)
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Total Debt Growth (5y) (2018 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 101.29 Mn | -61.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 155.53% |
| Mar 31, 2024 | 120.70% |
| Dec 31, 2023 | 141.09% |
| Jun 30, 2023 | 194.00% |
| Mar 31, 2023 | 147.01% |
| Dec 31, 2022 | 124.86% |
| Jun 30, 2022 | 245.50% |
| Mar 31, 2022 | 162.33% |
| Dec 31, 2021 | 135.05% |
| Jun 30, 2021 | 281.97% |
| Mar 31, 2021 | 189.80% |
| Dec 31, 2020 | 158.84% |
| Jun 30, 2020 | -11.44% |
| Mar 31, 2020 | 42.96% |
| Dec 31, 2019 | 39.13% |
| Jun 30, 2019 | 40.08% |
| Dec 31, 2018 | -9.18% |